← FDA Drug Approvals (Drugs@FDA)

LANSOPRAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PERRIGO R AND D · Approved 2012-05-18

Drug application

FDA Application #
ANDA202319
Application type
Abbreviated New Drug Application (Generic)
Brand name
LANSOPRAZOLE
Generic name
LANSOPRAZOLE
Active ingredients
LANSOPRAZOLE
Dosage form
CAPSULE, DELAYED REL PELLETS
Route
ORAL
Marketing status
Over-the-counter
Sponsor
PERRIGO R AND D
Manufacturer
Amazon.com Services LLC
First approval
2012-05-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown